United States Antimony Corporation reported a 16% year-over-year revenue increase to $10.1 million for Q3 2026, driven by antimony sales to the DLA. Despite strong gross profit growth, the company posted a significant net loss of $9.5 million, largely due to non-cash items and an unrealized investment loss, which could temper investor enthusiasm despite operational improvements.
United States Antimony Corporation (UAMY) announced its Q3 2026 financial results, showing a 16% revenue increase and a substantial 113% rise in gross profit, indicating strong operational performance in its core business. However, the reported net loss of $9.5 million, primarily due to non-cash items like stock-based compensation, depreciation, and a $3.8 million unrealized loss on an investment, overshadows the positive revenue and gross profit figures. This mixed bag of results presents a short-term challenge for investor sentiment, as the headline net loss might deter some despite underlying operational strength in antimony sales, particularly to the DLA. The long-term implications depend on whether the company can convert its operational gains into net profitability and manage its investment portfolio more effectively. Traders should watch for how the market weighs the operational improvements against the significant net loss.